The International Tennis Integrity Agency (ITIA) announced on November 28 that the violation was unintentional, attributing the positive test to contamination in a regulated melatonin product she used for jet lag and sleep issues. Swiatek accepted a one-month suspension, retroactively served, allowing her to compete again by December 4, reports Xinhua.<\/p>\r\n\r\n
\"My reaction was very intense\u2014confusion, panic, a lot of crying,\" Swiatek told Polish media. \"It felt like something terrible had happened to my health or career.\"<\/p>\r\n\r\n
The Pole revealed she spent significant resources -- $70,000 on legal fees and \u20ac15,000 on expert tests -- to clear her name. \"The most important thing was to prove my innocence,\" she said. Swiatek expressed relief that the ordeal ended swiftly. \"I can start the new season with a clean slate and focus on playing,\" she concluded.<\/p>\r\n\r\n
The ITIA has accepted that the prohibited substance was because of a contaminated regulated medication, which results in a \"No Significant Fault or Negligence finding\", thus handing a one-month suspension.<\/p>\r\n\r\n
\"The International Tennis Integrity Agency (ITIA) today confirms that Iga Swiatek, a 23-year-old tennis player from Poland, has accepted a one-month suspension under the Tennis Anti-Doping Programme, after testing positive for the prohibited substance trimetazidine (TMZ) in an out-of-competition sample in August 2024,\" the ITIA informed.<\/p>\r\n\r\n
The ITIA has accepted that the prohibited substance was because of a contaminated regulated medication, which results in a \"No Significant Fault or Negligence finding\", thus handing a one-month suspension.<\/p>\r\n\r\n
Also Read: <\/b> Highest tax paying cricketers<\/a><\/p>\r\n\r\n